|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 735 USD | -2.77% |
|
+0.20% | +26.08% |
| May. 03 | News Highlights : Top Company News of the Day - Friday at 5 PM ET | DJ |
| May. 03 | News Highlights : Top Company News of the Day - Friday at 7 PM ET | DJ |
Jan 11 (Reuters) - The U.S. Food and Drug Administration said on Thursday that a preliminary review by the agency had not found evidence of a link that GLP-1 weight loss drugs like Novo Nordisk's Wegovy are tied to an increase in suicidal thoughts.
However, the agency said it was continuing to look into the issue. (Reporting by Manas Mishra in Bengaluru; Editing by Shailesh Kuber)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 850.6 DKK | -2.58% | -4.06% | 546B | ||
| 735 USD | -2.77% | +0.20% | 662B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +26.08% | 662B | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B | |
| -3.40% | 157B |
ELI LILLY AND COMPANY 
